Rocket Pharmaceuticals, Inc. (RCKT)
$2.56-2.66%Close
SELLCRISIS · day 13
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $280M
- Beta
- 0.50
- P/E (TTM)
- -15.50
- Short % float
- 17.31%
- Days to cover
- 6.9
- SI change
- +1.4%
- 1W
- +0.00%
- 1M
- -26.44%
- vs SPY 1W
- -1.16%
- vs SPY 1M
- -29.43%
Industry peers
FMP comparable companies · ranked by market cap
- LBRXSELLLB Pharmaceuticals Inc Common Stock$1.1BCRISISQ 80$37.22+7.54%
- DSGNSELLDesign Therapeutics, Inc.$728MCRISISQ -12$11.65+1.39%
- AURASELLAura Biosciences, Inc.$676MRECOVERYQ -6$6.54+0.46%
- SLDBSELLSolid Biosciences Inc.$676MCRISISQ -13$6.87+0.73%
- ANNXSELLAnnexon, Inc.$659MRECOVERYQ -8$4.02+0.50%
- IMABI-Mab$542M$2.88
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
